Ann: Appendix 4C, page-6

I hope you are right as AXP hasn't got much time to get it right at this level of cash burn. I don't think much more can be cut from costs without affecting sales.

I am a little concern about what looks a bit like channel stuffing in the Australian market. How many of these pre-sales will turn into real sales? We should not see the summer effect in the Australian market so I was hoping we would get some sales number to doctors to see if we are seeing growth in Australia.

I have been waiting for some sign of growth so I can buy back in. I don't mind paying a little more for the privilege, but without serious sales growth numbers it is hard to see anything other than a downward spiral in the SP. I hope for everyone they knock it out of the park in the Dec qtr.